AF Association News & Events
HIGH RISK AF PATIENTS DENIED ACCESS TO LIFE-SAVING TREATMENT
Heart For Heart Initiative Launched To Improve Smartphone Performance of Arrhythmia Detection
Happitech, Arrhythmia Alliance and Bug Labs will announce the launch of the Heart for Heart e-health initiative. This initiative invites people to participate in the world’s largest crowdsourced heart health initiative by inviting them to contribute their heart rhythm data using the free Heart for Heart iPhone App.
Londoners advised to know their pulse during Heart Rhythm Week
Londoners are being invited to take a free, 30-second pulse check during Heart Rhythm Week. This simple check could prolong or even save their life. Heart rhythm disorders (arrhythmias) happen when a heart rhythm is too fast, too slow, or jumping around (irregular).
News - Londoners advised 'know your pulse' during Heart Rhythm Week
Londoners are being invited to take a free, 30 second pulse check during Heart Rhythm Week. This simple check could prolong or even save their life. Heart rhythm disorders (arrhythmia) happen when a heart rhythm is too fast, too slow, or jumping around (irregular).
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits. Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Pharmacists Demand Radical Reform of Care For People With Long Term Conditions
Community pharmacists must be able to routinely prescribe medicines for people with long term conditions and refer them directly to other healthcare professionals to ease the overwhelming demand facing the NHS says the Royal Pharmaceutical Society (RPS) in a new report to be launched at the House of Commons on 30th November.
New medical grade single lead ECG on your WRIST helps discover possible Atrial Fibrillation, a leading cause of stroke in the UK
Arrhythmia Alliance places 3000th Public Access Defibrillator on World Restart the Heart Day
“AEDs must be as commonplace as fire extinguishers and smoke alarms if we are to dramatically reduce the number of deaths from sudden cardiac arrest in the UK.”
New real-world analysis reports lower risk of major bleeding with dabigatran compared to rivaroxaban in stroke prevention
Ingelheim, Germany, 13.October 2016 – A large observational study by researchers from the U.S. FDA has found that dabigatran (150 mg twice daily) was associated with lower rates of intracranial haemorrhage and major extracranial bleeding, including major gastrointestinal bleeding than rivaroxaban (20 mg once daily) in patients with atrial fibrillation (AF). The study is the largest observational study to-date comparing the two drugs, and analysed data from over 118,000 AF patients. Based on the data published in JAMA Internal Medicine, the accompanying Editor’s Note written by Parks and Redberg suggests that physicians should “prescribe dabigatran over rivaroxaban for patients with atrial fibrillation.”
HEART RHYTHM CONGRESS DEBATES NEED FOR SCREENING OF UNKNOWN OR UNDIAGNOSED ATRIAL FIBRILLATION (AF)
Thursday 13 October, Heart Rhythm Congress, Birmingham, UK: Many of the world’s leading authorities on the management and treatment of atrial fibrillation (AF) met at the Heart Rhythm Congress to debate the latest evidence supporting the value of screening for people with unknown AF.